 Connection
Thomas Beresford to Humans
This is a "connection" page, showing publications Thomas Beresford has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.285 |
|
|
|
-
Beresford TP, Ronan PJ, Taub J, Learned B, Mi Z, Anderson M. Working Toward a Gold Standard: The Severity of Ethanol Withdrawal Scale (SEWS) Versus the Clinical Institute Withdrawal Assessment Alcohol Scale (CIWA-Ar). Alcohol Alcohol. 2023 May 09; 58(3):324-328.
Score: 0.022
-
Beresford T, Ronan PJ, Hipp D, Schmidt B, Thumm EB, Temple B, Wortzel H, Weitzenkamp D, Emrick C, Kelly J, Arciniegas DB. A Double-Blind Placebo-Controlled, Randomized Trial of Divalproex Sodium for Posttraumatic Irritability Greater Than 1 Year After Mild to Moderate Traumatic Brain Injury. J Neuropsychiatry Clin Neurosci. 2022; 34(3):224-232.
Score: 0.020
-
Ronan PJ, Flynn SA, Beresford TP. Calcineurin signaling as a target for the treatment of alcohol abuse and neuroinflammatory disorders. Prog Mol Biol Transl Sci. 2019; 167:125-142.
Score: 0.017
-
Beresford TP, Lucey MR. Towards Standardizing the Alcoholism Evaluation Of Potential Liver Transplant Recipients. Alcohol Alcohol. 2018 Mar 01; 53(2):135-144.
Score: 0.015
-
Beresford T, Buchanan J, Thumm EB, Emrick C, Weitzenkamp D, Ronan PJ. Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence. J Clin Psychopharmacol. 2017 Dec; 37(6):657-663.
Score: 0.015
-
Ronan PJ, Wongngamnit N, Beresford TP. Molecular Mechanisms of Cannabis Signaling in the Brain. Prog Mol Biol Transl Sci. 2016; 137:123-47.
Score: 0.013
-
Beresford TP. Medications for alcohol use disorders. JAMA. 2014 Oct 01; 312(13):1350.
Score: 0.012
-
Beresford TP. Clinical assessment of psychological adaptive mechanisms in medical settings. J Clin Psychol. 2014 May; 70(5):466-77.
Score: 0.012
-
Beresford TP, Wongngamnit N, Temple BA. Alcoholism: diagnosis, prognosis, epidemiology, and burden of the disease. Handb Clin Neurol. 2014; 125:3-13.
Score: 0.011
-
Arciniegas DB, Beresford TP. Managing difficult interactions with patients in neurology practices: a practical approach. Neurology. 2010 Nov 02; 75(18 Suppl 1):S39-44.
Score: 0.009
-
Beresford TP. What is addiction, what is alcoholism? Liver Transpl. 2007 Nov; 13(11 Suppl 2):S55-8.
Score: 0.007
-
Martin B, Beresford TP. Disulfiram in context: structure and safety. J Clin Psychopharmacol. 2007 Aug; 27(4):415-7; author reply 417-8.
Score: 0.007
-
Morfin JP, Kulig C, Everson G, Beresford T. Controlling for serum albumin level improves the correlation between serum fatty acid ethyl esters and blood ethanol level. Alcohol Clin Exp Res. 2007 Feb; 31(2):265-8.
Score: 0.007
-
Beresford TP, Arciniegas DB, Alfers J, Clapp L, Martin B, Beresford HF, Du Y, Liu D, Shen D, Davatzikos C, Laudenslager ML. Hypercortisolism in alcohol dependence and its relation to hippocampal volume loss. J Stud Alcohol. 2006 Nov; 67(6):861-7.
Score: 0.007
-
Beresford TP, Arciniegas DB, Alfers J, Clapp L, Martin B, Du Y, Liu D, Shen D, Davatzikos C. Hippocampus volume loss due to chronic heavy drinking. Alcohol Clin Exp Res. 2006 Nov; 30(11):1866-70.
Score: 0.007
-
Beresford TP. Probabilities of relapse and abstinence among liver transplant recipients. Liver Transpl. 2006 May; 12(5):705-6.
Score: 0.007
-
Beresford TP, Alfers J, Mangum L, Clapp L, Martin B. Cancer survival probability as a function of ego defense (adaptive) mechanisms versus depressive symptoms. Psychosomatics. 2006 May-Jun; 47(3):247-53.
Score: 0.007
-
Beresford TP. Dear Edith Edith S. L. Gomberg, PhD January 14, 1920-January 9, 2005. Alcohol Clin Exp Res. 2006 Feb; 30(2):177.
Score: 0.007
-
Beresford TP. Learning to recognize ego defense mechanisms: results of a structured teaching experience for psychiatric residents. Acad Psychiatry. 2005 Nov-Dec; 29(5):474-8.
Score: 0.006
-
Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF. Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol. 2005 Aug; 25(4):363-6.
Score: 0.006
-
Martin B, Mangum L, Beresford TP. Use of court-ordered supervised disulfiram therapy at DVA medical centers in the United States. Am J Addict. 2005 May-Jun; 14(3):208-12.
Score: 0.006
-
Beresford TP, Arciniegas D, Clapp L, Martin B, Alfers J. Reduction of affective lability and alcohol use following traumatic brain injury: a clinical pilot study of anti-convulsant medications. Brain Inj. 2005 Apr; 19(4):309-13.
Score: 0.006
-
Kulig CC, Beresford TP. Hepatitis C in alcohol dependence:drinking versus disulfiram. J Addict Dis. 2005; 24(2):77-89.
Score: 0.006
-
Martin B, Alfers J, Kulig C, Clapp L, Bialkowski D, Bridgeford D, Beresford TP. Disulfiram therapy in patients with hepatitis C: a 12-month, controlled, follow-up study. J Stud Alcohol. 2004 Sep; 65(5):651-7.
Score: 0.006
-
Beresford TP, Martin B, Alfers J. Developing a brief monitoring procedure for alcohol-dependent liver graft recipients. Psychosomatics. 2004 May-Jun; 45(3):220-3.
Score: 0.006
-
Martin BK, Clapp L, Alfers J, Beresford TP. Adherence to court-ordered disulfiram at fifteen months: a naturalistic study. J Subst Abuse Treat. 2004 Apr; 26(3):233-6.
Score: 0.006
-
Clapp L, Martin B, Beresford TP. Sublingual cocaine: novel recurrence of an ancient practice. Clin Neuropharmacol. 2004 Mar-Apr; 27(2):93-4.
Score: 0.006
-
Martin B, Clapp L, Bialkowski D, Bridgeford D, Amponsah A, Lyons L, Beresford TP. Compliance to supervised disulfiram therapy: a comparison of voluntary and court-ordered patients. Am J Addict. 2003 Mar-Apr; 12(2):137-43.
Score: 0.005
-
Zisook S, Johnson GR, Hicks P, Chen P, Beresford T, Michalets JP, Rao S, Thase ME, Wilcox J, Sevilimedu V, Mohamed S. Continuation phase treatment outcomes for switching, combining, or augmenting strategies for treatment-resistant major depressive disorder: A VAST-D report. Depress Anxiety. 2021 02; 38(2):185-195.
Score: 0.005
-
Mohamed S, Johnson GR, Chen P, Hicks PB, Davis LL, Yoon J, Gleason TC, Vertrees JE, Weingart K, Tal I, Scrymgeour A, Lawrence DD, Planeta B, Thase ME, Huang GD, Zisook S, Rao SD, Pilkinton PD, Wilcox JA, Iranmanesh A, Sapra M, Jurjus G, Michalets JP, Aslam M, Beresford T, Anderson KD, Fernando R, Ramaswamy S, Kasckow J, Westermeyer J, Yoon G, D'Souza DC, Larson G, Anderson WG, Klatt M, Fareed A, Thompson SI, Carrera CJ, Williams SS, Juergens TM, Albers LJ, Nasdahl CS, Villarreal G, Winston JL, Nogues CA, Connolly KR, Tapp A, Jones KA, Khatkhate G, Marri S, Suppes T, LaMotte J, Hurley R, Mayeda AR, Niculescu AB, Fischer BA, Loreck DJ, Rosenlicht N, Lieske S, Finkel MS, Little JT. Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial. JAMA. 2017 Jul 11; 318(2):132-145.
Score: 0.004
-
Clark BJ, Keniston A, Douglas IS, Beresford T, Macht M, Williams A, Jones J, Burnham EL, Moss M. Healthcare utilization in medical intensive care unit survivors with alcohol withdrawal. Alcohol Clin Exp Res. 2013 Sep; 37(9):1536-43.
Score: 0.003
-
Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, Kahn R, Chiang N, Beresford T, Campbell J, Haning W, Mawhinney J, McCann M, Rawson R, Stock C, Weis D, Yu E, Elkashef AM. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):135-41.
Score: 0.002
-
Kahn R, Biswas K, Childress AR, Shoptaw S, Fudala PJ, Gorgon L, Montoya I, Collins J, McSherry F, Li SH, Chiang N, Alathari H, Watson D, Liberto J, Beresford T, Stock C, Wallace C, Gruber V, Elkashef A. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug Alcohol Depend. 2009 Jul 01; 103(1-2):59-64.
Score: 0.002
-
Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv. 2006 Jul; 57(7):927-36.
Score: 0.002
-
Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M. Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatr Serv. 2006 Jul; 57(7):937-45.
Score: 0.002
-
Kulig CC, Beresford TP, Everson GT. Rapid, accurate, and sensitive fatty acid ethyl ester determination by gas chromatography-mass spectrometry. J Lab Clin Med. 2006 Mar; 147(3):133-8.
Score: 0.002
-
Fenn HH, Bauer MS, Altshuler L, Alshuler L, Evans DR, Williford WO, Kilbourne AM, Beresford TP, Kirk G, Stedman M, Fiore L. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord. 2005 May; 86(1):47-60.
Score: 0.002
-
Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO, Hauger R. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord. 2005 Apr; 85(3):301-15.
Score: 0.002
-
Kilbourne AM, Bauer MS, Pincus H, Williford WO, Kirk GF, Beresford T. Clinical, psychosocial, and treatment differences in minority patients with bipolar disorder. Bipolar Disord. 2005 Feb; 7(1):89-97.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|